Keyphrases
Ototoxicity
100%
Hearing Impairment
100%
Thiopurine Methyltransferase
100%
Pharmacodynamic Biomarker
100%
Pan-European
50%
Meta-analysis
50%
Clinically Significant
50%
Genetic Predisposition
50%
Biomaterials
50%
Genetic Association
50%
Cisplatin-induced Hearing Loss
50%
Cisplatin Ototoxicity
50%
Genotype
50%
Pharmacogenetics
50%
GSTP1
50%
Critical Genes
50%
ABCC3
50%
ACYP2
50%
NFE2L2
50%
WFS1
50%
LRP2
50%
Genetic Association Studies
50%
SLC22A2
50%
Cross-sectional Cohort Study
50%
Diagnostic Accuracy
50%
European Population
50%
Superoxide Dismutase 2 (SOD2)
50%
Genetic Markers
50%
Audiogram
50%
Pediatric Cancer Survivors
50%
Pharmacogenetic Association Studies
50%
Biochemistry, Genetics and Molecular Biology
Pharmacogenetics
100%
Candidate Gene
66%
Cisplatin
66%
Genotyping
66%
Thiopurine Methyltransferase
66%
Genetic Predisposition
33%
Genetic Association
33%
Cohort Study
33%
Genetic Association Study
33%
NFE2L2
33%
ABCC3
33%
WFS1
33%
SLC22A2
33%
SOD2
33%
LRP2
33%
GSTP1
33%
Genetic Marker
33%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacogenetics
100%
Ototoxicity
100%
Hearing Impairment
100%
Cisplatin
66%
Thiopurine Methyltransferase
66%
Malignant Neoplasm
33%
Cohort Study
33%
Genetic Predisposition
33%
Biomaterial
33%
Neuroscience
Cisplatin
100%
Thiopurine Methyltransferase
100%
Meta-Analysis
50%
NFE2L2
50%
Genetic Marker
50%